Company Listing
Dynogen Pharmaceuticals

Dynogen was developing a portfolio of therapies for gastrointestinal and genitourinary disorders. Due to deteriorating market conditions a previously announced purchase by a Special Purpose Acquisition Company was later cancelled and Dynogen was unable to secure further financing after the clinical data in one of its programmes was not sufficiently positive. The company was placed in administration in February 2009.

BACK
Location
Waltham, Massachusetts

Home

About Us

  1. About Us
  2. Our Team
  3. Transatlantic Reach
  4. Funds

Strategy

  1. Our Strategy
  2. Venture Capital
  3. Clinical Co‑development
  4. VIPEs
  5. Public Markets

Portfolio

  1. Portfolio Companies
  2. Case Studies

Media Centre

  1. Recent News
  2. Archived News
  3. Film

Contact

  1. Contact Us
  2. Send Us Your Proposal
Company Listing

Dynogen was developing a portfolio of therapies for gastrointestinal and genitourinary disorders. Due to deteriorating market conditions a previously announced purchase by a Special Purpose Acquisition Company was later cancelled and Dynogen was unable to secure further financing after the clinical data in one of its programmes was not sufficiently positive. The company was placed in administration in February 2009.

Location
Waltham, Massachusetts
BACK
 
Copyright Abingworth 2017